Akiko Kobori

683 citations
9 papers · 217 indexed · h-index 9
Topics
Advanced Glycation End Products research (4 papers)Alcoholism and Thiamine Deficiency (3 papers)Diabetes and associated disorders (3 papers)
Partner nations
Japan

In The Last Decade

Akiko Kobori

9 papers receiving 212 citations

Peers

Akiko Kobori
Comparison fields: 5 of 58
  • Clinical Biochemistry 64
  • Molecular Biology 54
  • Immunology 52
  • Physiology 39
  • Biological Psychiatry 31
Replace Anaïs Thouin with:
Anaïs Thouin United Kingdom
Elżbieta Szmida Poland
Xiuyu Shi China
Yanbin Jia China
Leonard E. Maroun United States
Amber Lockridge United States
Alya Qari Saudi Arabia
Stephanie N. Giamberardino United States
Alexandra G Moyzis United States
John Konen United States
Akiko Kobori relative to Anaïs Thouin United Kingdom Anaïs Thouin's profile →
Citations per field
00.5×3.7×
Anaïs Thouin · 1×
Citations per year

Countries citing papers authored by Akiko Kobori

Since Specialization
Citations

This map shows the geographic impact of Akiko Kobori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiko Kobori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiko Kobori more than expected).

Fields of papers citing papers by Akiko Kobori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiko Kobori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiko Kobori. The network helps show where Akiko Kobori may publish in the future.

Co-authorship network of co-authors of Akiko Kobori

This figure shows the co-authorship network connecting the top 25 collaborators of Akiko Kobori. A scholar is included among the top collaborators of Akiko Kobori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiko Kobori. Akiko Kobori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1 9
2 39
3 14
4 29
5 46
6
Self and Coping Among College Students in Japan
17
7 22
8 23
9 18

About Akiko Kobori

Akiko Kobori is a scholar working on Clinical Biochemistry, Biological Psychiatry and Neurology, having authored 9 papers that have together received 217 indexed citations. Recurring topics across this work include Advanced Glycation End Products research (4 papers), Alcoholism and Thiamine Deficiency (3 papers) and Diabetes and associated disorders (3 papers). The work is most often cited by research in Biological Psychiatry (31 citations), Clinical Biochemistry (64 citations) and Immunology (52 citations). Akiko Kobori has collaborated with scholars based in Japan. Frequent co-authors include Mitsuhiro Miyashita, Masanari Itokawa, Makoto Arai, Kazuya Toriumi, Katsuto Hozumi, Yasue Horiuchi, Sonoko Habu, Takehito Sato, Takashi Nishimura and Naoji Amano. Their work appears in journals such as PLoS ONE, Biochemical and Biophysical Research Communications and European Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026